Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Chronic-Phase trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Phase 2 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20091
20121
20142
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Institut Paoli-Calmettes2
European Organisation for Research and Treatment of Cancer - EORTC1
Hybrigenics Corporation1
Takeda1
Versailles Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase9
Burkitt Lymphoma3
Congenital Abnormalities3
Hodgkin Disease3
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Acute3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.